Product NDC: | 0456-3330 |
Proprietary Name: | Campral |
Non Proprietary Name: | acamprosate calcium |
Active Ingredient(s): | 333 mg/1 & nbsp; acamprosate calcium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0456-3330 |
Labeler Name: | Forest Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021431 |
Marketing Category: | NDA |
Start Marketing Date: | 20050111 |
Package NDC: | 0456-3330-60 |
Package Description: | 180 TABLET, DELAYED RELEASE in 1 DOSE PACK (0456-3330-60) |
NDC Code | 0456-3330-60 |
Proprietary Name | Campral |
Package Description | 180 TABLET, DELAYED RELEASE in 1 DOSE PACK (0456-3330-60) |
Product NDC | 0456-3330 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acamprosate calcium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20050111 |
Marketing Category Name | NDA |
Labeler Name | Forest Laboratories, Inc. |
Substance Name | ACAMPROSATE CALCIUM |
Strength Number | 333 |
Strength Unit | mg/1 |
Pharmaceutical Classes |